Amprius Technologies Inc (AMPX) Q2 2024 Earnings Call Highlights: Revenue Soars Amidst Profitability Challenges

Amprius Technologies Inc (AMPX) reports impressive revenue growth but faces hurdles with negative gross margins and manufacturing optimization.

Author's Avatar
Oct 09, 2024
Summary
  • Total Revenue: $3.3 million, all from product revenue.
  • Revenue Growth: 43% sequential increase; 105% year-over-year increase.
  • Gross Margin: Negative 195% for the quarter.
  • Operating Expenses: $6.4 million, a 9% increase from Q1 2024.
  • Net Loss: $12.5 million, or $0.13 per share.
  • Cash Position: $46.4 million in net cash, no debt.
  • Customer Shipments: Shipped to 56 customers, including 24 new customers.
  • Geographical Shipment Growth: 41% increase in the U.S.; 271% increase internationally.
  • New Sales Orders: $7.6 million, a 32% increase in net backlog from Q1.
  • Employee Count: 88 full-time employees as of June 30, 2024.
Article's Main Image

Release Date: August 08, 2024

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • Amprius Technologies Inc (AMPX, Financial) reported a significant increase in revenue, with a 105% year-over-year growth, driven by shipments to 56 customers, including 24 new ones.
  • The company has developed a strong patent portfolio with over 80 issued patents and applications, showcasing its leadership in silicon anode battery technology.
  • Amprius Technologies Inc (AMPX) has expanded its manufacturing capacity significantly, with access to approximately 10 million pouch cells and 125 million cylindrical cells annually.
  • The company has secured a $1.9 million contract from the US Army's xTechPrime program, highlighting its growing recognition and potential in the defense sector.
  • Amprius Technologies Inc (AMPX) has achieved third-party validation for its latest 500 Wh/kg, 1300 Wh/L battery platform, which is expected to be ready for commercial shipments later this year.

Negative Points

  • Amprius Technologies Inc (AMPX) reported a negative gross margin of 195% for the quarter, indicating ongoing challenges in achieving profitability.
  • The company faces uncertainties related to the construction and cost estimation of its planned manufacturing facility in Brighton, Colorado, which could impact future operations.
  • Amprius Technologies Inc (AMPX) is still in the process of optimizing its manufacturing processes in Fremont, California, which may delay full production capacity.
  • The company is exposed to potential risks from changes in government policies and market dynamics, which could affect its strategic plans and operations.
  • Despite significant manufacturing capacity, Amprius Technologies Inc (AMPX) needs to accelerate customer qualification processes to grow revenue, indicating potential delays in market penetration.

Q & A Highlights

Q: Can you discuss the design cycles and timelines for SiCore capacity and when significant customer volumes might start?
A: Kang Sun, CEO: We introduced SiCore in January 2024. Customers need to go through a two-step qualification process: product qualification, which takes 9 to 12 months, and production qualification. Some customers are already in the second stage, and we expect more progress by September. Typically, this process takes 9 to 18 months, depending on project size and complexity.

Q: Regarding the $7.6 million in new bookings, is that all SiMaxx, and what is the timeline for these orders?
A: Sandra Wallach, CFO: The bookings are across both SiMaxx and SiCore, with most expected in the upcoming quarters. Some large orders from AALTO Airbus include commitments through 2025, but the majority are for the next few quarters.

Q: How are you interpreting the sequential decrease in customer count from Q1 to Q2?
A: Kang Sun, CEO: The change in customer count does not indicate fewer customers. Many customers are evaluating samples, and during this period, we shipped additional samples, which are not counted in our shipments.

Q: Is the 50% revenue from outside the US in Q2 expected to continue, or was it an outlier?
A: Kang Sun, CEO: We aim to expand our market reach globally, not just in the US and Europe but also including Asia. This is part of our strategy to grow our market engagement.

Q: Are you fully committed to building the Colorado facility, or could you contract manufacture both SiCore and SiMaxx offerings to preserve capital?
A: Kang Sun, CEO: We have significant SiCore manufacturing capacity for the next few years. However, as a manufacturing company, we need our own facility, which is why we are still working on the Colorado factory. We are evaluating market dynamics and political factors before finalizing our plans.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.